(IN BRIEF) AstraZeneca is set to revolutionize cancer care with a slew of groundbreaking data presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting. Over 100 abstracts will showcase 25 approved and potential new medicines, including two late-breaking … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ADRIATIC, American Society of Clinical Oncology (ASCO) 2024, AstraZeneca, cancer care, Dave Fredrickson, DESTINY-Breast06, Enhertu, Imfinzi, Laura, Susan Galbraith, Tagrisso
(IN BRIEF) Sartorius, a prominent life science group, is expanding its collaboration with NVIDIA to advance the development of new therapies by integrating NVIDIA’s AI-powered computing platforms with Sartorius’ expertise in life sciences and bioprocessing. Since 2020, Sartorius has integrated … Read the full press release
(IN BRIEF) WACKER is strategically enhancing its BIOSOLUTIONS life-science division by bolstering capacities in biopharmaceuticals for advanced therapies. Its subsidiary, Wacker Biotech US, based in San Diego, is expanding mRNA and protein production to meet the surging demand for contract … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged advanced therapies, biopharmaceutical, Dr. Philippe Cronet, partnership, sustainability, USA, WACKER
(IN BRIEF) AstraZeneca has finalized its equity investment with Cellectis, a clinical-stage biotechnology firm, following a successful research collaboration agreement announced in November 2023. This partnership aims to harness Cellectis’ gene editing technologies to design up to 10 novel cell … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Cell and Gene Therapy Development, Cellectis, France, investment, partnership
(IN BRIEF) Bayer and Evotec have updated their strategic collaboration to focus on developing precision treatments for cardiovascular diseases (CVDs). Leveraging Evotec’s expertise in disease modelling using human induced pluripotent stem cells (iPSCs), the collaboration aims to identify and validate … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Bayer, Cardiovascular Therapies, Dr Cord Dohrmann, Dr. Christian Rommel, Evotec, Juergen Eckhardt, partnership, sustainability
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated significant progress in treating HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapy. The high-level results from the DESTINY-Breast06 Phase … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Breast Cancer Patients, Daiichi Sankyo, DESTINY-Breast06, Enhertu, HER2-Low, HER2-Ultralow, Ken Takeshita, partnership, safety, Susan Galbraith
(IN BRIEF) AstraZeneca’s Truqap, in combination with Faslodex, has received a positive recommendation from the European Medicines Agency (EMA) for treating estrogen receptor-positive, HER2‑negative locally advanced or metastatic breast cancer with specific genetic alterations. The recommendation follows promising results from … Read the full press release
(IN BRIEF) Evonik has enhanced its capabilities for RESOMER® powder biomaterials at its Darmstadt site in Germany with the implementation of advanced solvent-free micronization technology. This innovation allows for the production of customized powders with varied particle sizes and material … Read the full press release
(IN BRIEF) Evotec Biologics, the biologics arm of Evotec SE, has introduced its proprietary J.CHO™ High Expression System for antibody expression. J.CHO™ optimizes biotherapeutic production processes by providing higher productivity and quality for complex antibody formats. Engineered from Chinese hamster … Read the full press release
(IN BRIEF) Sanofi’s experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis (MS). Presented at the American Academy of Neurology Annual Meeting, the data reveals sustained reduction in disease activity and favorable … Read the full press release
Posted in Business, Education, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged CD40L antibody, Erik Wallström, Frexalimab, multiple sclerosis, Patrick Vermersch, safety, Sanofi
(IN BRIEF) Evotec SE announces the appointment of Aurélie Dalbiez as their new Chief People Officer (CPO), effective June 15, 2024. Joining the Management Board, Aurélie brings over 25 years of international Human Resources leadership experience, previously serving as the … Read the full press release
Posted in Business, Germany, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged appointment, Aurélie Dalbiez, Chief People Officer, Dr Mario Polywka, Evotec, leadership
(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in treating relapsing multiple sclerosis (RMS) over a span of up to six years. The study, presented at the American Academy … Read the full press release
(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release
(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Ireland, Management, News, Pharma & Biotech, Science, Technology
Tagged Bosch, Dr. Peter Fitzgerald, Healthcare, Marc Meier, Molecular Diagnostics, partnership, Randox Labs, Stefan Hartung
(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant Farmak Group to facilitate its strategic acquisition of a Polish pharmaceutical company and to upgrade its IT systems. Farmak, a … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Poland, Science, Technology, Ukraine, United Kingdom
Tagged acquisition, EBRD, expansion, Farmak, Frederic Lucenet, investment, partnership, Poland, sustainability, UKRAINE
(IN BRIEF) WACKER’s mRNA competence center in Halle is gearing up to produce an active ingredient for combatting acute respiratory distress syndrome (ARDS) in collaboration with Pantherna Therapeutics. The center, equipped with four new production lines, will more than triple … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged ARDS Treatment, Dr. Guido Seidel, Dr. Jörg Kaufmann, mRNA Production, PAN004, Pantherna, partnership, sustainability, WACKER
(IN BRIEF) AstraZeneca announces positive outcomes from the ADRIATIC Phase III trial, revealing that its immunotherapy drug Imfinzi (durvalumab) demonstrated a significant improvement in overall survival (OS) and progression-free survival (PFS) among patients with limited-stage small cell lung cancer (LS-SCLC) … Read the full press release
(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (ceftobiprole medocaril sodium for injection). The approval covers its use in adult patients with Staphylococcus aureus bloodstream infections (bacteremia), … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Adesh Kaul, Basilea, David Veitch, Dr. Marc Engelhardt, FDA, Pediatric Use, safety, Severe Bacterial Infections, Thomas Holland, Vance G. Fowler, Zevtera®
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been acknowledged by the US FDA for treating adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received prior systemic … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Biologics License Application (BLA), Breast Cancer Treatment, Daiichi Sankyo, datopotamab deruxtecan, Japan, Ken Takeshita, partnership, safety, Susan Galbraith, sustainability, US FDA
(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Beyfortus, Dr. Hiroyuki Moriuchi, France, Iskra Reic, Japan, LRTD, partnership, prophylaxis, respiratory syncytial virus, safety, Sanofi, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?